Posters

Uveitis-glaucoma-hyphema syndrome treated with haptic amputation

Poster Details

First Author: D.Tabibian SWITZERLAND

Co Author(s):    M. El Wardani   G. Kymionis   A. Petrovic   O. Richoz   K. Hashemi   T. Wolfensberger     

Abstract Details

Purpose:

to report the case of a patient with uveitis-glaucoma-hyphema syndrome with a dislocated posterior chamber lens that was successfully surgically managed with an isolated haptic amputation after failure of conservative management.

Setting:

case report, Jules-Gonin Eye Hospital, Ophtalmology dpt, University Hospital of Lausanne

Methods:

a 75 years-old gentleman presented to our eye casualty unit with severe pain in his right eye. Examination showed visual acuity of 0.5, 50mmHg intraocular pressure, mild corneal edema, mild anterior uveitis and hyphema on gonioscopy. The iris presented a superior transilluminating defect caused by the IOL haptic dislocation. The patient was initially successfully managed conservatively with maximum topical and oral eye pressure lowering therapy. However two weeks later he presented a second episode despite maximal conservative treatment. After controlling the pressure and inflammation the dislocated lens haptic was surgically managed with amputation at its base with the optic.

Results:

at the first postoperative day, the uncorrected visual acuity in his right eye was 0.2 and the IOP was 11 mmHg. Slit lamp examination showed +1 cells and flare in the anterior chamber and the IOL was stable in the bag. On his last examination, 10 months postoperatively, the uncorrected visual acuity was 1.0, the IOL was slightly displaced superiorly, mainly on the nasal side, but stable and fortunately there was no effect on his visual acuity. The anterior chamber was deep and quiet and the IOP was 11 mmHg under no treatment.

Conclusions:

successful surgical management of uveitis-glaucoma-hyphema syndrome can be performed with minimal surgery such as haptic amputation in order to avoid complications linked to full IOL exchange.

Financial Disclosure:

None